Skip to main content
Fig. 2 | Nano Convergence

Fig. 2

From: Bioenzyme-based nanomedicines for enhanced cancer therapy

Fig. 2

Reproduced with permission from [39]. Copyright 2020, Wiley–VCH

a Schematic illustration of the intracellular co-delivery of RNase A and DOX using a multistage cooperative drug delivery nanoplatform formed by mPEG-b-PGCA-b-PGTA for combination cancer therapy. b Tumor volume changes of B16F10-tumor-bearing mice after intravenous injection of PBS, NP-RNBC, NP-DOX, DOX, and NP-DOX-RNBC on day 0, 3, 6, and 9. c Relative tumor volume of the mice treated as described in (b) on day 14. Inset: Representative photographs of the excised tumors from the mice treated as described in (b) on day 14.

Back to article page